论文部分内容阅读
目的分析及比较TICL植入术和ICL植入联合SBK两种方法治疗高度近视合并散光的疗效。方法分别对38例高度近视合并散光患者行TICL植入术和ICL植入联合SBK手术。其中行TICL植入的患者为26例，共48只眼。 ICL植入联合SBK的患者为12例，共22只眼。术前平均近视度数为11.69±2.51D，平均散光度数为2.15±1.02D。于术后1d、1年进行随访。随访内容包括裸眼视力，最佳矫正视力、球镜度数、散光度数、TICL轴向旋转情况。结果术后1dTICL组裸眼视力提高至4.82±0.32；ICL联合SBK组提高至4.87±0.22，两种手术有效性指数无显著差异。术后1年TICL组最佳矫正视力提高至4.96±0.29；ICL联合LASIK组最佳矫正视力提高至4.95±0.82。两种手术安全性无显著差异(>0.01)。术后1年，TICL残余等效球镜为0.78±0.26D；ICL联合LASIK组残余等效球镜为0.83±0.14D。两者无显著差异。结论TICL植入术和ICL植入联合SBK是治疗高度近视合并散光有效、安全的方法。两者在有效性和安全性方面没有显著性差异。“,”Objective To evaluate and compare the ef icacy safety and stability of the two methods:TICL implantation and ICL implantation associating with SBK (ICL+SBK) in treating high myopia with a astigmatism.Methods TICL implantation was performed in 48 eyes of 26 patients with high myopia with a astigmatism. ICL+SBK was performed in 22 eyes of 16 patients. The evaluation included uncor ected visual acuity (UCVA), best corrected visual acuity (BCVA),spherical equivalent refraction uncor ected.Results 1 day after operation, UCVA in TICL group has been increased 4.82±0.32 and that in ICL was 4.87±0.22. There is no significant dif erence in ef icacy between two groups ( >0.01).1 year after operation BCVA in TICL group has been increased to 4.96±0.29;that in ICL+SBK was 4.95±0.82.There is no significant dif erence in safety between two groups ( >0.01).1 year after operation the spherical equivalent refraction uncorrected in TICL group is 0.78±0.26 D, that was 0.83±0.14D in ICL+SBK group. There is no significant dif erence between two groups ( >0.01).Conclusion TICL implantation and ICL implantation associating with SBK are both ef ective and safe methods in treating high myopia with a astigmatism. There are no significant dif erence in ef icacy and safety between two groups.